We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide (Mebendazole)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01729260
Recruitment Status : Active, not recruiting
First Posted : November 20, 2012
Last Update Posted : January 23, 2018
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : September 2016
  Study Completion Date : No date given